AeroVanc
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Savara Inc.
Overview
AeroVanc is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AeroVanc clinical trials
Explore related
Medical disclaimer. This page summarizes research about AeroVanc for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.